APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Propofol and Ciprofol Injections

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Propofol and Ciprofol Injections Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174029100322 December 2025194 pages

Choose your research edition.

Industry ResearchPropofol and Ciprofol Injections Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Propofol and Ciprofol Injections Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Propofol and Ciprofol Injections Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propofol and Ciprofol Injections Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Propofol and Ciprofol Injections Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Propofol and Ciprofol Injections market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Propofol and Ciprofol Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Propofol and Ciprofol Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Propofol and Ciprofol Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Propofol and Ciprofol Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Propofol and Ciprofol Injections include Xi’an Libang Pharmaceutical, Sichuan Kelun Pharmaceutical, Haisco Pharmaceutical Group, Jiangsu Yingke Biopharmaceutical, Pfizer, Guangdong Jiabo Pharmaceutical, Fresenius Kabi, Jiangsu Nhwa Pharmaceutical and B. Braun, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Propofol and Ciprofol Injections market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Propofol and Ciprofol Injections and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Propofol and Ciprofol Injections sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Propofol and Ciprofol Injections market size, projected growth trends, production technologies, key applications, and end-use industries.

Propofol and Ciprofol Injections Segment by Company

Xi’an Libang Pharmaceutical

Sichuan Kelun Pharmaceutical

Haisco Pharmaceutical Group

Jiangsu Yingke Biopharmaceutical

Pfizer

Guangdong Jiabo Pharmaceutical

Fresenius Kabi

Jiangsu Nhwa Pharmaceutical

B. Braun

Beijing Sciecure Pharmaceutical

Sichuan Biokin Pharmaceutical

AstraZeneca

Wellona Pharma

Rusoma

NEON

Flagship Biotech

Dr. Reddy's Laboratories

Centurion Healthcare

Propofol and Ciprofol Injections Segment by Type

Propofol Injections

Ciprofol Injections

Propofol and Ciprofol Injections Segment by Application

Gastrointestinal Endoscopy

Anesthesia for Surgery

Other

Propofol and Ciprofol Injections Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol and Ciprofol Injections market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propofol and Ciprofol Injections and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol and Ciprofol Injections.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Propofol and Ciprofol Injections market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Propofol and Ciprofol Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Propofol and Ciprofol Injections in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Propofol and Ciprofol Injections in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Propofol and Ciprofol Injections Industry Trends Table 2. Propofol and Ciprofol Injections Industry Drivers Table 3. Propofol and Ciprofol Injections Industry Opportunities and Challenges Table 4. Propofol and Ciprofol Injections Industry Restraints Table 5. Global Propofol and Ciprofol Injections Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Propofol and Ciprofol Injections Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Propofol and Ciprofol Injections Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Propofol and Ciprofol Injections Sales Market Share by Manufacturers Table 9. Global Propofol and Ciprofol Injections Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Propofol and Ciprofol Injections Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Propofol and Ciprofol Injections Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Propofol and Ciprofol Injections Manufacturers, Product Type & Application Table 13. Global Propofol and Ciprofol Injections Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Propofol and Ciprofol Injections by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Propofol Injections Table 17. Major Manufacturers of Ciprofol Injections Table 18. Global Propofol and Ciprofol Injections Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Propofol and Ciprofol Injections Sales by Type (2021-2026) & (k units) Table 20. Global Propofol and Ciprofol Injections Sales by Type (2027-2032) & (k units) Table 21. Global Propofol and Ciprofol Injections Sales Market Share by Type (2021-2026) Table 22. Global Propofol and Ciprofol Injections Sales Market Share by Type (2027-2032) Table 23. Global Propofol and Ciprofol Injections Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Propofol and Ciprofol Injections Revenue by Type (2021-2026) & (k units) Table 25. Global Propofol and Ciprofol Injections Revenue by Type (2027-2032) & (k units) Table 26. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2021-2026) Table 27. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Gastrointestinal Endoscopy Table 29. Major Manufacturers of Anesthesia for Surgery Table 30. Major Manufacturers of Other Table 31. Global Propofol and Ciprofol Injections Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Propofol and Ciprofol Injections Sales by Application (2021-2026) & (k units) Table 33. Global Propofol and Ciprofol Injections Sales by Application (2027-2032) & (k units) Table 34. Global Propofol and Ciprofol Injections Sales Market Share by Application (2021-2026) Table 35. Global Propofol and Ciprofol Injections Sales Market Share by Application (2027-2032) Table 36. Global Propofol and Ciprofol Injections Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Propofol and Ciprofol Injections Revenue by Application (2021-2026) & (k units) Table 38. Global Propofol and Ciprofol Injections Revenue by Application (2027-2032) & (k units) Table 39. Global Propofol and Ciprofol Injections Revenue Market Share by Application (2021-2026) Table 40. Global Propofol and Ciprofol Injections Revenue Market Share by Application (2027-2032) Table 41. Global Propofol and Ciprofol Injections Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Propofol and Ciprofol Injections Sales by Region (2021-2026) & (k units) Table 43. Global Propofol and Ciprofol Injections Sales Market Share by Region (2021-2026) Table 44. Global Propofol and Ciprofol Injections Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Propofol and Ciprofol Injections Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Propofol and Ciprofol Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Propofol and Ciprofol Injections Sales by Country (2021-2026) & (k units) Table 48. North America Propofol and Ciprofol Injections Sales by Country (2027-2032) & (k units) Table 49. Europe Propofol and Ciprofol Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Propofol and Ciprofol Injections Sales by Country (2021-2026) & (k units) Table 51. Europe Propofol and Ciprofol Injections Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Propofol and Ciprofol Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Propofol and Ciprofol Injections Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Propofol and Ciprofol Injections Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Propofol and Ciprofol Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Propofol and Ciprofol Injections Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Propofol and Ciprofol Injections Sales by Country (2027-2032) & (k units) Table 58. Global Propofol and Ciprofol Injections Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Propofol and Ciprofol Injections Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Propofol and Ciprofol Injections Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Propofol and Ciprofol Injections Revenue Market Share by Region (2021-2026) Table 62. Global Propofol and Ciprofol Injections Revenue Market Share by Region (2027-2032) Table 63. Xi’an Libang Pharmaceutical Company Information Table 64. Xi’an Libang Pharmaceutical Business Overview Table 65. Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 67. Xi’an Libang Pharmaceutical Recent Development Table 68. Sichuan Kelun Pharmaceutical Company Information Table 69. Sichuan Kelun Pharmaceutical Business Overview Table 70. Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 72. Sichuan Kelun Pharmaceutical Recent Development Table 73. Haisco Pharmaceutical Group Company Information Table 74. Haisco Pharmaceutical Group Business Overview Table 75. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product Portfolio Table 77. Haisco Pharmaceutical Group Recent Development Table 78. Jiangsu Yingke Biopharmaceutical Company Information Table 79. Jiangsu Yingke Biopharmaceutical Business Overview Table 80. Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 82. Jiangsu Yingke Biopharmaceutical Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Pfizer Propofol and Ciprofol Injections Product Portfolio Table 87. Pfizer Recent Development Table 88. Guangdong Jiabo Pharmaceutical Company Information Table 89. Guangdong Jiabo Pharmaceutical Business Overview Table 90. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 92. Guangdong Jiabo Pharmaceutical Recent Development Table 93. Fresenius Kabi Company Information Table 94. Fresenius Kabi Business Overview Table 95. Fresenius Kabi Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Fresenius Kabi Propofol and Ciprofol Injections Product Portfolio Table 97. Fresenius Kabi Recent Development Table 98. Jiangsu Nhwa Pharmaceutical Company Information Table 99. Jiangsu Nhwa Pharmaceutical Business Overview Table 100. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 102. Jiangsu Nhwa Pharmaceutical Recent Development Table 103. B. Braun Company Information Table 104. B. Braun Business Overview Table 105. B. Braun Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. B. Braun Propofol and Ciprofol Injections Product Portfolio Table 107. B. Braun Recent Development Table 108. Beijing Sciecure Pharmaceutical Company Information Table 109. Beijing Sciecure Pharmaceutical Business Overview Table 110. Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 112. Beijing Sciecure Pharmaceutical Recent Development Table 113. Sichuan Biokin Pharmaceutical Company Information Table 114. Sichuan Biokin Pharmaceutical Business Overview Table 115. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 117. Sichuan Biokin Pharmaceutical Recent Development Table 118. AstraZeneca Company Information Table 119. AstraZeneca Business Overview Table 120. AstraZeneca Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. AstraZeneca Propofol and Ciprofol Injections Product Portfolio Table 122. AstraZeneca Recent Development Table 123. Wellona Pharma Company Information Table 124. Wellona Pharma Business Overview Table 125. Wellona Pharma Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Wellona Pharma Propofol and Ciprofol Injections Product Portfolio Table 127. Wellona Pharma Recent Development Table 128. Rusoma Company Information Table 129. Rusoma Business Overview Table 130. Rusoma Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Rusoma Propofol and Ciprofol Injections Product Portfolio Table 132. Rusoma Recent Development Table 133. NEON Company Information Table 134. NEON Business Overview Table 135. NEON Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. NEON Propofol and Ciprofol Injections Product Portfolio Table 137. NEON Recent Development Table 138. Flagship Biotech Company Information Table 139. Flagship Biotech Business Overview Table 140. Flagship Biotech Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Flagship Biotech Propofol and Ciprofol Injections Product Portfolio Table 142. Flagship Biotech Recent Development Table 143. Dr. Reddy's Laboratories Company Information Table 144. Dr. Reddy's Laboratories Business Overview Table 145. Dr. Reddy's Laboratories Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Dr. Reddy's Laboratories Propofol and Ciprofol Injections Product Portfolio Table 147. Dr. Reddy's Laboratories Recent Development Table 148. Centurion Healthcare Company Information Table 149. Centurion Healthcare Business Overview Table 150. Centurion Healthcare Propofol and Ciprofol Injections Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Centurion Healthcare Propofol and Ciprofol Injections Product Portfolio Table 152. Centurion Healthcare Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Propofol and Ciprofol Injections Distributors List Table 156. Propofol and Ciprofol Injections Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Propofol and Ciprofol Injections Product Image Figure 2. Global Propofol and Ciprofol Injections Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Propofol and Ciprofol Injections Market Size (2021-2032) & (US$ Million) Figure 4. Global Propofol and Ciprofol Injections Sales (2021-2032) & (k units) Figure 5. Global Propofol and Ciprofol Injections Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Propofol and Ciprofol Injections Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Propofol Injections Image Figure 9. Ciprofol Injections Image Figure 10. Global Propofol and Ciprofol Injections Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Propofol and Ciprofol Injections Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Propofol and Ciprofol Injections Sales Market Share by Type (2021-2032) Figure 13. Global Propofol and Ciprofol Injections Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Propofol and Ciprofol Injections Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2021-2032) Figure 16. Gastrointestinal Endoscopy Image Figure 17. Anesthesia for Surgery Image Figure 18. Other Image Figure 19. Global Propofol and Ciprofol Injections Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Propofol and Ciprofol Injections Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Propofol and Ciprofol Injections Sales Market Share by Application (2021-2032) Figure 22. Global Propofol and Ciprofol Injections Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Propofol and Ciprofol Injections Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Propofol and Ciprofol Injections Revenue Market Share by Application (2021-2032) Figure 25. North America Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Propofol and Ciprofol Injections Sales Market Share by Country (2021-2032) Figure 27. U.S. Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Propofol and Ciprofol Injections Sales Market Share by Country (2021-2032) Figure 32. Germany Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Propofol and Ciprofol Injections Sales Market Share by Country (2021-2032) Figure 39. China Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Propofol and Ciprofol Injections Sales Market Share by Country (2021-2032) Figure 47. Brazil Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Propofol and Ciprofol Injections Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Propofol and Ciprofol Injections Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Propofol and Ciprofol Injections Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Figure 58. North America Propofol and Ciprofol Injections Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Figure 60. Europe Propofol and Ciprofol Injections Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Propofol and Ciprofol Injections Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Propofol and Ciprofol Injections Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Propofol and Ciprofol Injections Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Propofol and Ciprofol Injections Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Propofol Injections
  • Ciprofol Injections
Applications
  • Gastrointestinal Endoscopy
  • Anesthesia for Surgery
  • Other
Companies covered
  • Xi’an Libang Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Haisco Pharmaceutical Group
  • Jiangsu Yingke Biopharmaceutical
  • Pfizer
  • Guangdong Jiabo Pharmaceutical
  • Fresenius Kabi
  • Jiangsu Nhwa Pharmaceutical
  • B. Braun
  • Beijing Sciecure Pharmaceutical
  • Sichuan Biokin Pharmaceutical
  • AstraZeneca
  • Wellona Pharma
  • Rusoma
  • NEON
  • Flagship Biotech
  • Dr. Reddy's Laboratories
  • Centurion Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Propofol and Ciprofol Injections Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Propofol and Ciprofol Injections Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Propofol and Ciprofol Injections Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Propofol and Ciprofol Injections Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Propofol and Ciprofol Injections Market Dynamics
  1. 2.1 Propofol and Ciprofol Injections Industry Trends
  2. 2.2 Propofol and Ciprofol Injections Industry Drivers
  3. 2.3 Propofol and Ciprofol Injections Industry Opportunities and Challenges
  4. 2.4 Propofol and Ciprofol Injections Industry Restraints
3 Propofol and Ciprofol Injections Market by Manufacturers
  1. 3.1 Global Propofol and Ciprofol Injections Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Propofol and Ciprofol Injections Sales by Manufacturers (2021-2026)
  3. 3.3 Global Propofol and Ciprofol Injections Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Propofol and Ciprofol Injections Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Propofol and Ciprofol Injections Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Propofol and Ciprofol Injections Manufacturers, Product Type & Application
  7. 3.7 Global Propofol and Ciprofol Injections Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Propofol and Ciprofol Injections Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Propofol and Ciprofol Injections Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Propofol and Ciprofol Injections Tier 1, Tier 2, and Tier 3
4 Propofol and Ciprofol Injections Market by Type
  1. 4.1 Propofol and Ciprofol Injections Type Introduction
  2. 4.1.1 Propofol Injections
  3. 4.1.2 Ciprofol Injections
  4. 4.2 Global Propofol and Ciprofol Injections Sales by Type
  5. 4.2.1 Global Propofol and Ciprofol Injections Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Propofol and Ciprofol Injections Sales by Type (2021-2032)
  7. 4.2.3 Global Propofol and Ciprofol Injections Sales Market Share by Type (2021-2032)
  8. 4.3 Global Propofol and Ciprofol Injections Revenue by Type
  9. 4.3.1 Global Propofol and Ciprofol Injections Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Propofol and Ciprofol Injections Revenue by Type (2021-2032)
  11. 4.3.3 Global Propofol and Ciprofol Injections Revenue Market Share by Type (2021-2032)
5 Propofol and Ciprofol Injections Market by Application
  1. 5.1 Propofol and Ciprofol Injections Application Introduction
  2. 5.1.1 Gastrointestinal Endoscopy
  3. 5.1.2 Anesthesia for Surgery
  4. 5.1.3 Other
  5. 5.2 Global Propofol and Ciprofol Injections Sales by Application
  6. 5.2.1 Global Propofol and Ciprofol Injections Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Propofol and Ciprofol Injections Sales by Application (2021-2032)
  8. 5.2.3 Global Propofol and Ciprofol Injections Sales Market Share by Application (2021-2032)
  9. 5.3 Global Propofol and Ciprofol Injections Revenue by Application
  10. 5.3.1 Global Propofol and Ciprofol Injections Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Propofol and Ciprofol Injections Revenue by Application (2021-2032)
  12. 5.3.3 Global Propofol and Ciprofol Injections Revenue Market Share by Application (2021-2032)
6 Global Propofol and Ciprofol Injections Sales by Region
  1. 6.1 Global Propofol and Ciprofol Injections Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Propofol and Ciprofol Injections Sales by Region (2021-2032)
  3. 6.2.1 Global Propofol and Ciprofol Injections Sales by Region (2021-2026)
  4. 6.2.2 Global Propofol and Ciprofol Injections Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Propofol and Ciprofol Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Propofol and Ciprofol Injections Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Propofol and Ciprofol Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Propofol and Ciprofol Injections Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Propofol and Ciprofol Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Propofol and Ciprofol Injections Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Propofol and Ciprofol Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Propofol and Ciprofol Injections Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Propofol and Ciprofol Injections Revenue by Region
  1. 7.1 Global Propofol and Ciprofol Injections Revenue by Region
  2. 7.1.1 Global Propofol and Ciprofol Injections Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Propofol and Ciprofol Injections Revenue by Region (2021-2026)
  4. 7.1.3 Global Propofol and Ciprofol Injections Revenue by Region (2027-2032)
  5. 7.1.4 Global Propofol and Ciprofol Injections Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Propofol and Ciprofol Injections Revenue (2021-2032)
  8. 7.2.2 North America Propofol and Ciprofol Injections Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Propofol and Ciprofol Injections Revenue (2021-2032)
  11. 7.3.2 Europe Propofol and Ciprofol Injections Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Propofol and Ciprofol Injections Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Propofol and Ciprofol Injections Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Propofol and Ciprofol Injections Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Propofol and Ciprofol Injections Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Xi’an Libang Pharmaceutical
  2. 8.1.1 Xi’an Libang Pharmaceutical Company Information
  3. 8.1.2 Xi’an Libang Pharmaceutical Business Overview
  4. 8.1.3 Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  6. 8.1.5 Xi’an Libang Pharmaceutical Recent Developments
  7. 8.2 Sichuan Kelun Pharmaceutical
  8. 8.2.1 Sichuan Kelun Pharmaceutical Company Information
  9. 8.2.2 Sichuan Kelun Pharmaceutical Business Overview
  10. 8.2.3 Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  12. 8.2.5 Sichuan Kelun Pharmaceutical Recent Developments
  13. 8.3 Haisco Pharmaceutical Group
  14. 8.3.1 Haisco Pharmaceutical Group Company Information
  15. 8.3.2 Haisco Pharmaceutical Group Business Overview
  16. 8.3.3 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product Portfolio
  18. 8.3.5 Haisco Pharmaceutical Group Recent Developments
  19. 8.4 Jiangsu Yingke Biopharmaceutical
  20. 8.4.1 Jiangsu Yingke Biopharmaceutical Company Information
  21. 8.4.2 Jiangsu Yingke Biopharmaceutical Business Overview
  22. 8.4.3 Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Product Portfolio
  24. 8.4.5 Jiangsu Yingke Biopharmaceutical Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Propofol and Ciprofol Injections Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Guangdong Jiabo Pharmaceutical
  32. 8.6.1 Guangdong Jiabo Pharmaceutical Company Information
  33. 8.6.2 Guangdong Jiabo Pharmaceutical Business Overview
  34. 8.6.3 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  36. 8.6.5 Guangdong Jiabo Pharmaceutical Recent Developments
  37. 8.7 Fresenius Kabi
  38. 8.7.1 Fresenius Kabi Company Information
  39. 8.7.2 Fresenius Kabi Business Overview
  40. 8.7.3 Fresenius Kabi Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Fresenius Kabi Propofol and Ciprofol Injections Product Portfolio
  42. 8.7.5 Fresenius Kabi Recent Developments
  43. 8.8 Jiangsu Nhwa Pharmaceutical
  44. 8.8.1 Jiangsu Nhwa Pharmaceutical Company Information
  45. 8.8.2 Jiangsu Nhwa Pharmaceutical Business Overview
  46. 8.8.3 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  48. 8.8.5 Jiangsu Nhwa Pharmaceutical Recent Developments
  49. 8.9 B. Braun
  50. 8.9.1 B. Braun Company Information
  51. 8.9.2 B. Braun Business Overview
  52. 8.9.3 B. Braun Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 B. Braun Propofol and Ciprofol Injections Product Portfolio
  54. 8.9.5 B. Braun Recent Developments
  55. 8.10 Beijing Sciecure Pharmaceutical
  56. 8.10.1 Beijing Sciecure Pharmaceutical Company Information
  57. 8.10.2 Beijing Sciecure Pharmaceutical Business Overview
  58. 8.10.3 Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  60. 8.10.5 Beijing Sciecure Pharmaceutical Recent Developments
  61. 8.11 Sichuan Biokin Pharmaceutical
  62. 8.11.1 Sichuan Biokin Pharmaceutical Company Information
  63. 8.11.2 Sichuan Biokin Pharmaceutical Business Overview
  64. 8.11.3 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  66. 8.11.5 Sichuan Biokin Pharmaceutical Recent Developments
  67. 8.12 AstraZeneca
  68. 8.12.1 AstraZeneca Company Information
  69. 8.12.2 AstraZeneca Business Overview
  70. 8.12.3 AstraZeneca Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AstraZeneca Propofol and Ciprofol Injections Product Portfolio
  72. 8.12.5 AstraZeneca Recent Developments
  73. 8.13 Wellona Pharma
  74. 8.13.1 Wellona Pharma Company Information
  75. 8.13.2 Wellona Pharma Business Overview
  76. 8.13.3 Wellona Pharma Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Wellona Pharma Propofol and Ciprofol Injections Product Portfolio
  78. 8.13.5 Wellona Pharma Recent Developments
  79. 8.14 Rusoma
  80. 8.14.1 Rusoma Company Information
  81. 8.14.2 Rusoma Business Overview
  82. 8.14.3 Rusoma Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Rusoma Propofol and Ciprofol Injections Product Portfolio
  84. 8.14.5 Rusoma Recent Developments
  85. 8.15 NEON
  86. 8.15.1 NEON Company Information
  87. 8.15.2 NEON Business Overview
  88. 8.15.3 NEON Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 NEON Propofol and Ciprofol Injections Product Portfolio
  90. 8.15.5 NEON Recent Developments
  91. 8.16 Flagship Biotech
  92. 8.16.1 Flagship Biotech Company Information
  93. 8.16.2 Flagship Biotech Business Overview
  94. 8.16.3 Flagship Biotech Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Flagship Biotech Propofol and Ciprofol Injections Product Portfolio
  96. 8.16.5 Flagship Biotech Recent Developments
  97. 8.17 Dr. Reddy's Laboratories
  98. 8.17.1 Dr. Reddy's Laboratories Company Information
  99. 8.17.2 Dr. Reddy's Laboratories Business Overview
  100. 8.17.3 Dr. Reddy's Laboratories Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Dr. Reddy's Laboratories Propofol and Ciprofol Injections Product Portfolio
  102. 8.17.5 Dr. Reddy's Laboratories Recent Developments
  103. 8.18 Centurion Healthcare
  104. 8.18.1 Centurion Healthcare Company Information
  105. 8.18.2 Centurion Healthcare Business Overview
  106. 8.18.3 Centurion Healthcare Propofol and Ciprofol Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Centurion Healthcare Propofol and Ciprofol Injections Product Portfolio
  108. 8.18.5 Centurion Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Propofol and Ciprofol Injections Value Chain Analysis
  2. 9.1.1 Propofol and Ciprofol Injections Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Propofol and Ciprofol Injections Production Mode & Process
  6. 9.2 Propofol and Ciprofol Injections Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Propofol and Ciprofol Injections Distributors
  9. 9.2.3 Propofol and Ciprofol Injections Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst